聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 1 小时 8 分钟 前

Nuviant Medical Names Brian Blischak Chief Commercial Officer

周二, 03/15/2016 - 16:13
Key Hire positions Nuviant for accelerated growth DALLAS, March 15, 2016 /PRNewswire-iReach/ -- Nuviant Medical, Inc. ("Nuviant" or "the Company"), a medical device development and manufacturing company with proprietary closed-loop n...
Devices, Neurology, Personnel
Nuviant Medical, neuromodulation

Dutch Medical Center Begins Radiosurgery Treatments with Elekta's Leksell Gamma Knife Icon

周二, 03/15/2016 - 16:10
Frameless, multisession Gamma Knife radiosurgery a new option at Tilburg hospital TILBURG, the Netherlands, March 15, 2016 -- (Healthcare Sales & Marketing Network) -- On January 11, the Gamma Knife Center at Elisabeth Tweesteden Ziekenhuis (ETZ, Tilb...
Devices, Oncology, Neurosurgery
Elekta, Leksell, Gamma Knife, radiosurgery, radiotherapy

Arterys Completes Series A Financing

周一, 03/14/2016 - 13:52
Funding from Emergent Medical Partners, GE Ventures and Other Leading Venture Investors Validates Future of Medical Imaging Technology SAN FRANCISCO, March 14, 2016 -- (Healthcare Sales & Marketing Network) -- Arterys Inc., a privately-held company ded...
Devices, Radiology, Venture Capital
Arterys, imaging, ViosWorks

ProNAi Therapeutics Granted Orphan Drug Designation for PNT2258 for the Treatment of Diffuse Large B-Cell Lymphoma

周一, 03/14/2016 - 13:41
VANCOUVER, March 14, 2016 -- (Healthcare Sales & Marketing Network) - ProNAi Therapeutics, Inc. (DNAI), a clinical-stage oncology company advancing novel therapeutics for patients with cancer and hematological diseases, today announced that its oncology d...
Biopharmaceuticals, Oncology, FDA
ProNAi Therapeutics, PNT2258, Orphan Drug, lymphoma

The European Association of Urology Upgrades UroLift(R) System Trial Data to its Highest Possible Classification - Level 1A - in its Guidelines

周一, 03/14/2016 - 13:31
Further evidence from two multi-national randomized studies presented at EAU conference supports durability of UroLift® System treatment for men with enlarged prostate MUNICH, March 14, 2016 -- (Healthcare Sales & Marketing Network) -- The UroLift ...
Devices, Urology
NeoTract, UroLift, Benign Prostatic Hyperplasia

Bantam Pharmaceutical Appoints Dr. Michael Luther President and CEO

周五, 03/11/2016 - 13:50
NEW YORK, March 11, 2016 -- (Healthcare Sales & Marketing Network) -- Bantam Pharmaceutical, LLC, a pharmaceutical company focused on the discovery and development of compounds to treat cancer with a focus on RNA translation, today, announced that the com...
Biopharmaceuticals, Personnel
Bantam Pharmaceutical

Eigen USA and Hitachi Medical Systems Europe Switzerland Announce a Collaborative Agreement for Hitachi to Distribute the Artemis, Eigen's Robotic 3D Targeted Prostate Biopsy Device

周五, 03/11/2016 - 13:43
The combined Hitachi Noblus and Artemis Eigen systems will be showcased at the European Association of Urology annual meeting in Munich, March 12th-14th, 2016, Booth #E16 ZUG, Switzerland, March 11, 2016 -- (Healthcare Sales & Marketing Network) -- Eig...
Devices, Oncology, Distribution
Hitachi Medical Systems, Artemis, Eigen, prostate biopsy

MedCom GmbH and Hitachi Medical Systems Europe Announce an Agreement to Distribute BiopSee(R), MedCom's Fusion Imaging System for Stereotactic, Navigated, Targeted Prostate Biopsy and Therapy Guidance, for use in Conjunction With Hitachi Ultrasound System

周五, 03/11/2016 - 13:34
The combined Hitachi Noblus and MedCom BiopSee® systems will be showcased at the European Association of Urology (EAU) annual meeting in Munich, March 12th-14th, 2016, Booth #E16 ZUG, Switzerland, March 11, 2016 -- (Healthcare Sales & Marketing Netw...
Devices, Radiology, Oncology, Distribution
Hitachi Medical Systems, MedCom GmbH, BiopSee, prostate biopsy

HeartStitch, Inc. Appoints Renowned Cardiac Surgeon to Its Clinical Advisory Board

周五, 03/11/2016 - 13:27
Dr. Yuriy Pya, Chief of Cardiac Surgery at the National Research Center for Cardiac Surgery, Kazakhstan's Top Cardiac Hospital, Joins HeartStitch(R) Clinical Advisory Board FOUNTAIN VALLEY, CA--(Healthcare Sales & Marketing Network) - HeartStitch®t...
Devices, Cardiology, Surgery, Personnel
HeartStitch, NobleStitch, vascular suture

Regeneron and Sanofi Announce Topline Results of Phase 3 Monotherapy Study Demonstrating Superiority of Sarilumab vs. Adalimumab in Patients with Active Rheumatoid Arthritis

周五, 03/11/2016 - 13:13
TARRYTOWN, N.Y. and PARIS, March 11, 2016 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that a Phase 3 monotherapy study met its primary endpoint demonstrating that sarilumab was sup...
Biopharmaceuticals
Regeneron Pharmaceuticals, Sanofi, sarilumab, rheumatoid arthritis

Revolutionary 3D Cardiac Mapping System Developed by Aurora Health Care Physician Receives FDA Clearance

周四, 03/10/2016 - 14:58
MILWAUKEE, WI--(Healthcare Sales & Marketing Network) - Dr. Jasbir Sra, an internationally recognized cardiac electrophysiologist with Aurora Health Care, has received clearance from the Food and Drug Administration (FDA) to market a new three-dimensional ...
Devices, Cardiology, Radiology, FDA
Aurora Health Care, Navik 3D, cardiac mapping, atrial fibrillation

ProMark(R) Prostate Cancer Prognostic Now Included in NCCN Guidelines

周四, 03/10/2016 - 14:51
Metamark continues to advocate for broader adoption of precision medicine in prostate cancer care CAMBRIDGE, Mass., March 10, 2016 -- (Healthcare Sales & Marketing Network) -- Metamark Genetics, Inc., ("Metamark" or the "Company"), ...
Diagnostics, Oncology
Metamark Genetics, ProMark, prostate cancer, NCCN

Allergan Receives Complete Response Letter from FDA for Prior Approval Supplement for RESTASIS(R) (Cyclosporine Ophthalmic Emulsion) 0.05% Multi-Dose Preservative-Free Bottle

周四, 03/10/2016 - 14:48
DUBLIN, March 10, 2016 -- (Healthcare Sales & Marketing Network) -- Allergan plc (AGN) announced today it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its Prior Approval Supplement (PAS) for RESTASIS® (C...
Biopharmaceuticals, Ophthalmology, FDA
Allergan, RESTASIS, Cyclosporine, Chronic Dry Eye

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong